Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 5, 2005

Stroke. 2005
Published online before print May 5, 2005, doi: 10.1161/01.STR.0000166045.12976.af
A more recent version of this article appeared on June 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/1201    most recent
01.STR.0000166045.12976.afv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arenillas, J. F.
Right arrow Articles by Álvarez-Sabín, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arenillas, J. F.
Right arrow Articles by Álvarez-Sabín, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Exercise testing
Right arrow Risk Factors
Right arrow Nuclear cardiology and PET
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Primary and Secondary Stroke Prevention
Right arrow Lipid and lipoprotein metabolism

Submitted on November 9, 2004
Revised on December 29, 2004
Accepted on February 18, 2005

Silent Myocardial Ischemia in Patients With Symptomatic Intracranial Atherosclerosis. Associated Factors

Juan F. Arenillas MD, PhD*; Jaume Candell-Riera MD, PhD; Guillermo Romero-Farina MD, PhD; Carlos A. Molina MD, PhD; Pilar Chacón MD, PhD; Santiago Aguadé-Bruix MD; Joan Montaner MD, PhD; Gustavo de León MD; Joan Castell-Conesa MD, PhD; and José Álvarez-Sabín MD, PhD

From the Neurovascular Unit, Department of Neurology (J.F.A., C.A.M., J.M., J.A.-S.), Nuclear Cardiology Department (J.C.-R., G.R.-F.S.A.-B.G.dL., J.C.-C.), and Lipid Research Unit, Department of Biochemistry (P.C.), Vall d’Hebron Universitary Hospital, Barcelona, Spain.

* To whom correspondence should be addressed. E-mail: juanfarenillas{at}terra.es.

Background and Purpose--Optimization of coronary risk evaluation in stroke patients has been encouraged. The relationship between symptomatic intracranial atherosclerosis and occult coronary artery disease (CAD) has not been evaluated sufficiently. We aimed to investigate the prevalence of silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis and to identify factors associated with its presence.

Methods--From 186 first-ever transient ischemic attack or ischemic stroke patients with intracranial stenoses, 65 fulfilled selection criteria, including angiographic confirmation of a symptomatic atherosclerotic stenosis and absence of known CAD. All patients underwent a maximal-stress myocardial perfusion single-photon emission computed tomography (SPECT). Lipoprotein(a) [Lp(a)], C-reactive protein, and homocysteine (Hcy) levels were determined before SPECT.

Results--Stress-rest SPECT detected reversible myocardial perfusion defects in 34 (52%) patients. Vascular risk factors associated with a pathologic SPECT were hypercholesterolemia (P=0.045), presence of >2 risk factors (P=0.004) and high Lp(a) (P=0.023) and Hcy levels (P=0.018). Ninety percent of patients with high Lp(a) and Hcy levels had a positive SPECT. Existence of a stenosed intracranial internal carotid artery (ICA; odds ratio [OR], 7.22, 2.07 to 25.23; P=0.002) and location of the symptomatic stenosis in vertebrobasilar arteries (OR, 4.89, 1.19 to 20.12; P=0.027) were independently associated with silent myocardial ischemia after adjustment by age, sex, and risk factors.

Conclusions--More than 50% of the patients with symptomatic intracranial atherosclerosis and not overt CAD show myocardial perfusion defects on stress-rest SPECT. Stenosed intracranial ICA, symptomatic vertebrobasilar stenosis and presence of high Lp(a) and Hcy levels may characterize the patients at a higher risk for occult CAD.


Key words: coronary artery disease • homocysteine • intracranial atherosclerosis • tomography, emission computed, single-photon




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
P. Armario and A. de la Sierra
Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 197 - 204.
[Abstract] [PDF]